Aptamer launches funded folic acid fortification testing programme
8th Jun 2026 12:41
(Sharecast News) - Aptamer Group said on Monday that it had launched a funded research programme with Imperial College London to develop a rapid testing kit for folic acid levels in fortified foods.
Read moreAptamer shares slide despite revenue improvement
7th Jan 2026 14:13
(Sharecast News) - Aptamer Group shares were falling on Wednesday, after the company reported a 27% increase in first-half revenue and outlined progress across its licensing and partnership pipeline, as investors weighed the pace of commercial conversion and near-term financial visibility.
Read moreAptamer enters new financial year with growing commercial momentum
27th Nov 2025 15:04
(Sharecast News) - Aptamer Group said in an update on Thursday that it entered its new financial year with growing commercial momentum and increased visibility over revenue, supported by repeat business from major pharmaceutical clients and a strengthening order book.
Read moreAptamer grows order book with two new pharma contracts
14th Nov 2025 13:58
(Sharecast News) - Aptamer Group said on Friday that two new pharmaceutical contracts worth £0.19m had lifted its binding 2026 order book to £1.95m, marking continued commercial momentum and strengthening validation of its Optimer synthetic-binder platform among major global drugmakers.
Read moreAptamer signs contract with 'top five' pharma client
4th Nov 2025 16:01
(Sharecast News) - Aptamer Group announced on Tuesday that it has signed a new contract worth up to £0.62m with a top five global pharmaceutical company, marking the third collaboration between the two and further validating its 'Optimer' synthetic binder technology.
Read moreAptamer wins contract with 'top 10' repeat customer
13th Oct 2025 07:13
(Sharecast News) - Life sciences group Aptamer on Monday announced a new fee-for-service development contract with an unnamed top 10 global pharma company.
Read moreAptamer Group signs development contract with Metir
11th Sep 2025 14:39
(Sharecast News) - Aptamer Group said Thursday that it has signed a new contract with Metir to develop synthetic Optimer binders for rapid cryptosporidium detection in Metir's next-generation water pathogen monitoring platform.
Read moreDirector dealings: Aptamer chairman raises stake
9th Sep 2025 13:09
(Sharecast News) - Aptamer revealed on Tuesday that chairman Adam Hargreaves had acquired 5.0m ordinary shares in the AIM-listed synthetic binders developer.
Read moreAptamer reports progress across enzyme modulation pipeline
22nd Aug 2025 13:58
(Sharecast News) - Aptamer Group reported progress across its enzyme modulation pipeline on Friday, and confirmed strong commercial validation from a top five global pharmaceutical partner, underscoring the revenue potential of its Optimer technology platform.
Read moreAptamer secures contract extension with 'top five global pharma' partner
18th Aug 2025 10:30
(Sharecast News) - Biotechnology firm Aptamer said on Monday that it has secured an extension and new work order with a "top five global pharma partner".
Read moreAptamer gets more commissioned work from Unilever
21st Jul 2025 12:47
(Sharecast News) - Aptamer Group announced on Monday that it has received additional commissioned work from Unilever to support the ongoing development of its proprietary Optimer binders for use in deodorant products.
Read moreAptamer raises £2m to support expanding its Optimer technology
4th Jul 2025 11:51
(Sharecast News) - Aptamer Group announced on Friday that it has raised £2m through a placing of new shares to support the commercial expansion of its proprietary 'Optimer' technology and advance licensing negotiations for key assets.
Read moreAptamer signs second Optimer programme contract with Unilever
30th May 2025 09:42
(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.
Read moreDirector dealings: Conygar, Aptamer insiders buy shares
13th Jan 2025 14:57
(Sharecast News) - Two director share purchases disclosed to the market in London on Monday involved insiders at the Conygar Investment Company and Aptamer Group.
Read moreAptamer strikes new development contract agreement
19th Dec 2024 10:19
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up to £155,000.
Read more